IPP Bureau
Roche launches Elecsys HCV Duo immunoassay for hepatitis C virus
By IPP Bureau - July 20, 2022
Elecsys HCV Duo is the first commercially available immunoassay that allows the simultaneous and independent determination of the hepatitis C virus (HCV) antigen and antibody status.
Essential Pharma progress in its ESG performance
By IPP Bureau - July 20, 2022
The company now exceeds the sector benchmark for its overall ESG rating and for all three measures
Brii Bio inks partnership with China Resources Pharmaceutical to advance the commercialization of Long-acting COVID-19 neutralizing antibody therapy
By IPP Bureau - July 20, 2022
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China
GSK’s Haleon begins trading in LSE
By IPP Bureau - July 20, 2022
Completion of the demerger of Haleon and share consolidation of GSK
Lupin Diagnostics launches its first reference laboratory in Ranchi
By IPP Bureau - July 19, 2022
Lupin Diagnostics will equip doctors with accurate diagnosis in the patient journey by leveraging innovative technologies
Pharma manufacturer 'Gansons' turns 75
By IPP Bureau - July 18, 2022
Gansons is based in Thane (Maharashtra, India) with global representation in UK, USA, UAE, Central Asia, South Asia and South-East Asia.
India crosses ‘200 Crore’ COVID-19 vaccinations
By IPP Bureau - July 18, 2022
PM congratulates citizens on crossing the 200 crore milestone of Covid vaccination drive
NHA commences first Hackathon under the ‘ABDM Hackathon Series’ in Pune
By IPP Bureau - July 18, 2022
ABDM Hackathon Round 1 – Kickstarting Unified Health Interface (UHI) is being held from 14th to 17th July 2022 as a hybrid event
Orchid Pharma updates on PLI scheme benefits for its subsidiary
By IPP Bureau - July 18, 2022
The approval has been accorded by IFCI Limited for manufacturing of the product "7 ACA"
Jagsonpal Pharmaceuticals appoints Manish Gupta as the MD
By IPP Bureau - July 18, 2022
Manish led SeQuent since 2014 and played a major role in transforming the company
Glaucoma Research Foundation launches catalyst for a to prevent and cure neurodegeneration
By IPP Bureau - July 18, 2022
Groundbreaking collaborative research program will explore common characteristics of glaucoma, alzheimer's
Biotium introduces new line of antibodies for exosome detection
By IPP Bureau - July 18, 2022
ExoBrite antibody conjugates are validated and optimized for bright and specific detection of exosome markers
Zydus receives final approval from the USFDA for Efinaconazole Topical Solution
By IPP Bureau - July 18, 2022
Jublia (Efinaconazole) topical solution, 10% had annual sales of $292 million in the United States according to IQVIA data (IQVIA MAT May 2022).
Strand Life Sciences presents report on ‘Genomic Surveillance of SARS-CoV-2’
By IPP Bureau - July 18, 2022
Strand Life Sciences has sequenced a total of 12800 samples from July, 2021 to June, 2022, and identified more than a 100 lineages circulating in Bengaluru
Avet Pharmaceuticals appoints George Svokos as President &CEO
By IPP Bureau - July 18, 2022
George Svokos joins Avet after serving as a strategic business advisor to numerous global healthcare companies
